Nijag Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -72.22%
- Profit Growth -73.59%
- Ebitda 89.56%
- Net Worth 14.84%
- Total Assets -63.36%
About Nijag Pharmaceutical
Nijag Pharmaceutical Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 April 2018 (Six years and ten months 20 days old ). Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kishor Dhorajiya and Nitinkumar Dhorajiya serve as directors at the Company.
Company Details
- Location
Surat, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999GJ2018PTC101697
- Company No.
101697
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Pharma
What products or services does Nijag Pharmaceutical Private Limited offer?
Nijag Pharmaceutical Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Inflammatory and Immunosuppressant API, Pyridine Derivatives, 2-Chloro-5-methylpyridine, API (Active Pharmaceutical Ingredients), Antidepressant & Anti Anxiety Medicines, Pregabalin Powder, Blood System and Cardiovascular API, Pregabalin Capsules, Chemical Compound.
Who are the key members and board of directors at Nijag Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kishor Dhorajiya  | Director | 09-Apr-2018 | Current |
| Nitinkumar Dhorajiya | Director | 09-Apr-2018 | Current |
Financial Performance of Nijag Pharmaceutical.
Nijag Pharmaceutical Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 72.22% decrease. The company also saw a substantial fall in profitability, with a 73.59% decrease in profit. The company's net worth Soared by an impressive increase of 14.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nijag Pharmaceutical?
Unlock access to Nijag Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nijag Pharmaceutical?
Unlock and access historical data on people associated with Nijag Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nijag Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nijag Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.